Synthio Labs Secures $5 Million to Enhance Voice AI for Life Sciences

Synthio Labs has successfully raised $5 million in a seed funding round led by Elevation Capital, with contributions from 1984 Ventures, Peak XV Partners, Y Combinator, and numerous strategic angel investors. This funding will facilitate the growth of their engineering and product teams, bolster enterprise deployments in both the U.S. and Europe, and strengthen collaborations with leading global life sciences firms.

Established by Supreet Deshpande, Sahitya Sridhar, and Rajashekar Vasantha, Synthio Labs is committed to developing clinical-grade voice AI designed to enhance communication among life sciences companies, clinicians, and patients.

Innovative Product Offerings of Synthio Labs

Synthio’s AI operating system features three distinct products:

• Jarvis: A voice AI copilot tailored for field teams.
• Ather: A multimodal engine that enhances physician and patient engagement across various channels.
• Simulation Studio: A platform that creates digital twins of clinicians and patients for research and strategic purposes.

These innovative tools empower teams to automate conversations, gather structured insights, and ensure consistent communication.

Adoption Among Leading Companies

Several prominent pharmaceutical companies and direct-to-consumer healthcare brands are among the early adopters. In one notable instance, Synthio’s voice AI conducted 5,000 calls to eczema patients within just 48 hours, aiding in the processes of onboarding, screening, and providing assistance.